20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

Navigating the Supply Chain for Pharmaceutical Intermediates: A Focus on Imidazoles

The pharmaceutical industry relies heavily on complex supply chains for critical intermediates, and imidazole derivatives, such as 2-Propyl-1H-imidazole-4,5-dicarboxy acid (CAS: 58954-23-7), are no exception. These compounds are essential building blocks for numerous Active Pharmaceutical Ingredients (APIs), and ensuring a robust, reliable supply is paramount for drug manufacturers.

Understanding the supply chain for 2-Propyl-1H-imidazole-4,5-dicarboxy acid involves recognizing the key players: raw material suppliers, intermediate manufacturers, and the end-users (API producers). For buyers seeking to purchase this compound, a critical step is identifying reliable manufacturers who can consistently deliver the required quality and quantity. China is a significant hub for the production of such fine chemicals and pharmaceutical intermediates.

When evaluating suppliers, consider their production capacity, quality control measures, and adherence to international standards. A manufacturer that specializes in imidazole chemistry and has a proven history of producing pharmaceutical-grade intermediates like 2-Propyl-1H-imidazole-4,5-dicarboxy acid is ideal. This specialization ensures a deeper understanding of the synthesis process and potential challenges.

Furthermore, building strong relationships with suppliers is crucial. Open communication about forecasting demand, potential production challenges, and regulatory changes can help mitigate supply disruptions. For procurement managers, having a diversified supplier base can also provide a safety net.

The demand for 2-Propyl-1H-imidazole-4,5-dicarboxy acid is directly linked to the market for Olmesartan. As global demand for antihypertensive medications remains high, so does the need for this critical intermediate. Therefore, proactive sourcing and close collaboration with manufacturers and suppliers are essential to ensure uninterrupted production and timely delivery of finished pharmaceutical products.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Cost-Effective Sourcing of 2-Propyl-1H-imidazole-4,5-dicarboxy Acid from China

Next: Quality Assurance for Pharmaceutical Intermediates: The Case of 2-Propyl-1H-imidazole-4,5-dicarboxy Acid

All Rights Reserved